Pure Primary Nongestational Choriocarcinoma of the Ovary: A Case Report

Tsujioka, 2003, A pure nongestational choriocarcinoma of the ovary diagnosed with DNA polymorphism analysis, Gynecol Oncol, 89, 540, 10.1016/S0090-8258(03)00139-2 Vance, 1985, Pure nongestational choriocarcinoma of the ovary. Report of a case, Cancer, 56, 2321, 10.1002/1097-0142(19851101)56:9<2321::AID-CNCR2820560931>3.0.CO;2-Q Goswami, 2001, Nongestational pure ovarian choriocarcinoma with contralateral teratoma, Gynecol Oncol, 80, 262, 10.1006/gyno.2000.6043 Grover, 1990, Primary pure choriocarcinoma of the ovary, Gynecol Obstet Invest, 30, 61, 10.1159/000293216 Kurman, 1977, Malignant germ cell tumors of the ovary, Hum Pathol, 8, 551, 10.1016/S0046-8177(77)80115-9 Shigematsu, 2000, DNA polymorphism analysis of a pure non-gestational choriocarcinoma of the ovary: case report, Eur J Gynaecol Oncol, 21, 153 Jacobs, 1982, Pure choriocarcinoma of the ovary, Obstet Gynecol Surv, 37, 603, 10.1097/00006254-198210000-00001 Bagshawe, 1984, Treatment of high-risk choriocarcinoma, J Reprod Med, 29, 813 Schink, 1992, Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease, Obstet Gynecol, 80, 817 Hartenbach, 1995, A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease, Gynecol Oncol, 56, 105, 10.1006/gyno.1995.1019 Hammond, 1973, Treatment of metastatic trophoblastic disease: good and poor prognosis, Am J Obstet Gynecol, 115, 451, 10.1016/0002-9378(73)90389-X Axe, 1985, Choriocarcinoma of the ovary, Obstet Gynecol, 66, 111